Press release

Applied DNA Signs Memorandum of Understanding with Process Chemicals Leader Stahl to Bring CertainT® Platform to Manufacturing Supply Chains

0
Sponsored by Businesswire

Applied
DNA Sciences Inc.
 (NASDAQ: APDN) (“Applied DNA”, the “Company”), a
leader in PCR-based DNA manufacturing for product authenticity and
traceability solutions, announced today the signing of a non-binding
Memorandum of Understanding (“MOU”) with Netherlands-based Stahl, the
world leader in process chemicals for leather products, performance
coatings and other substrates. The MOU is expected to be followed by a
definitive agreement.

Under the terms of the MOU, the parties will continue the evaluation of
molecular tagging of process chemicals and coatings utilizing Stahl’s
product offerings as a point of entry into supply chains for the
Company’s molecular tags. Stahl will provide technical expertise to the
company relating to the process chemicals used in leather manufacturing.

Dr. James Hayward, President and CEO of Applied DNA, said, “Stahl’s
global sales and support footprint, coupled with broad access to its
customer base that spans global brands and their supply chains, makes it
an ideal partner through which to expand, implement and support our
CertainT® authentication and traceability platform. We
believe this partnership should accelerate our entry into the leather
market. We look forward to a long and productive relationship with
Stahl.”

Mike Costello, Director of Sustainability at Stahl, said “We see a
bright future for molecular tagging. Leather is just one of many
industries which could benefit by having the capability to improve
traceability. As a process chemical manufacturer, we are a logical point
of entry into a whole range of supply chains for Applied DNA’s molecular
tags.”

About Stahl

Stahl is the world leader in leather chemicals and high-performance
coatings. Our products provide functionality, durability and comfort to
many different materials used in everyday life. Through our continuous
focus on innovation and improving the environmental footprint, Stahl
adds value to differentiated high-end industries with a unique service
model for premium solutions. As part of its corporate responsibility,
Stahl is actively driving change in the industry by initiating
activities that promote transparency and to provide environmental
solutions for the supply chain, involving close collaboration with its
partners.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply
chain security, anti-counterfeiting and anti-theft technology, product
genotyping and pre-clinical nucleic acid-based therapeutic drug
candidates.

Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help protect
products, brands, entire supply chains, and intellectual property of
companies, governments and consumers from theft, counterfeiting, fraud
and diversion.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn.
Join our mailing list.

Common stock listed on NASDAQ under the symbol APDN, and warrants are
listed under the symbol APDNW.

Forward-Looking Statements

The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private Securities
Litigation Act of 1995. Forward-looking statements describe Applied
DNA’s future plans, projections, strategies and expectations, and are
based on assumptions and involve a number of risks and uncertainties,
many of which are beyond the control of Applied DNA. Actual results
could differ materially from those projected due to its history of net
losses, limited financial resources, limited market acceptance and
various other factors detailed from time to time in Applied DNA’s SEC
reports and filings, including our Annual Report on Form 10-K filed on
December 18, 2018 and our subsequent quarterly report on Form 10-Q filed
on February 7, 2019, and other reports we file with the SEC, which are
available at www.sec.gov.
Applied DNA undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or
circumstances after the date hereof to reflect the occurrence of
unanticipated events, unless otherwise required by law.